Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT

Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT

Background. To evaluate the clinical efficacy of In-111 DTPA octreotide SPECT/CT and Ga-68 DOTATOC PET/CT for detection of primary tumors in patients with either neuroendocrine tumor of unknown primary (NETUP) or clinically suspected primary NET (SNET).

Bibliographic Details
Main Authors: Schreiter Nils Friedemann, Bartels Ann-Mirja, Froeling Vera, Steffen Ingo, Pape Ulrich-Frank, Beck Alexander, Hamm Bernd, Brenner Winfried, Röttgen Rainer
Format: Article
Language:English
Published: Sciendo 2014-12-01
Series:Radiology and Oncology
Subjects:
net
cup
ga-68 dotatoc pet/ct
in-111 dtpa octreotide spect
clinically suspected net
Online Access:https://doi.org/10.2478/raon-2014-0018
id doaj-2a90f2264b024ec4890a53f2ba4cc06d
record_format Article
spelling doaj-2a90f2264b024ec4890a53f2ba4cc06d2021-09-05T14:01:18ZengSciendoRadiology and Oncology1581-32072014-12-0148433934710.2478/raon-2014-0018raon-2014-0018Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CTSchreiter Nils Friedemann0Bartels Ann-Mirja1Froeling Vera2Steffen Ingo3Pape Ulrich-Frank4Beck Alexander5Hamm Bernd6Brenner Winfried7Röttgen Rainer8Department of Nuclear Medicine, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Nuclear Medicine, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Radiology, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Nuclear Medicine, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Gastroenterology, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Radiology, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Radiology, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Nuclear Medicine, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Nuclear Medicine, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany / Department of Radiology, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyBackground. To evaluate the clinical efficacy of In-111 DTPA octreotide SPECT/CT and Ga-68 DOTATOC PET/CT for detection of primary tumors in patients with either neuroendocrine tumor of unknown primary (NETUP) or clinically suspected primary NET (SNET).https://doi.org/10.2478/raon-2014-0018netcupga-68 dotatoc pet/ctin-111 dtpa octreotide spectclinically suspected net
collection DOAJ
language English
format Article
sources DOAJ
author Schreiter Nils Friedemann
Bartels Ann-Mirja
Froeling Vera
Steffen Ingo
Pape Ulrich-Frank
Beck Alexander
Hamm Bernd
Brenner Winfried
Röttgen Rainer
spellingShingle Schreiter Nils Friedemann
Bartels Ann-Mirja
Froeling Vera
Steffen Ingo
Pape Ulrich-Frank
Beck Alexander
Hamm Bernd
Brenner Winfried
Röttgen Rainer
Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT
Radiology and Oncology
net
cup
ga-68 dotatoc pet/ct
in-111 dtpa octreotide spect
clinically suspected net
author_facet Schreiter Nils Friedemann
Bartels Ann-Mirja
Froeling Vera
Steffen Ingo
Pape Ulrich-Frank
Beck Alexander
Hamm Bernd
Brenner Winfried
Röttgen Rainer
author_sort Schreiter Nils Friedemann
title Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT
title_short Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT
title_full Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT
title_fullStr Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT
title_full_unstemmed Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT
title_sort searching for primaries in patients with neuroendocrine tumors (net) of unknown primary and clinically suspected net: evaluation of ga-68 dotatoc pet/ct and in-111 dtpa octreotide spect/ct
publisher Sciendo
series Radiology and Oncology
issn 1581-3207
publishDate 2014-12-01
description Background. To evaluate the clinical efficacy of In-111 DTPA octreotide SPECT/CT and Ga-68 DOTATOC PET/CT for detection of primary tumors in patients with either neuroendocrine tumor of unknown primary (NETUP) or clinically suspected primary NET (SNET).
topic net
cup
ga-68 dotatoc pet/ct
in-111 dtpa octreotide spect
clinically suspected net
url https://doi.org/10.2478/raon-2014-0018
work_keys_str_mv AT schreiternilsfriedemann searchingforprimariesinpatientswithneuroendocrinetumorsnetofunknownprimaryandclinicallysuspectednetevaluationofga68dotatocpetctandin111dtpaoctreotidespectct
AT bartelsannmirja searchingforprimariesinpatientswithneuroendocrinetumorsnetofunknownprimaryandclinicallysuspectednetevaluationofga68dotatocpetctandin111dtpaoctreotidespectct
AT froelingvera searchingforprimariesinpatientswithneuroendocrinetumorsnetofunknownprimaryandclinicallysuspectednetevaluationofga68dotatocpetctandin111dtpaoctreotidespectct
AT steffeningo searchingforprimariesinpatientswithneuroendocrinetumorsnetofunknownprimaryandclinicallysuspectednetevaluationofga68dotatocpetctandin111dtpaoctreotidespectct
AT papeulrichfrank searchingforprimariesinpatientswithneuroendocrinetumorsnetofunknownprimaryandclinicallysuspectednetevaluationofga68dotatocpetctandin111dtpaoctreotidespectct
AT beckalexander searchingforprimariesinpatientswithneuroendocrinetumorsnetofunknownprimaryandclinicallysuspectednetevaluationofga68dotatocpetctandin111dtpaoctreotidespectct
AT hammbernd searchingforprimariesinpatientswithneuroendocrinetumorsnetofunknownprimaryandclinicallysuspectednetevaluationofga68dotatocpetctandin111dtpaoctreotidespectct
AT brennerwinfried searchingforprimariesinpatientswithneuroendocrinetumorsnetofunknownprimaryandclinicallysuspectednetevaluationofga68dotatocpetctandin111dtpaoctreotidespectct
AT rottgenrainer searchingforprimariesinpatientswithneuroendocrinetumorsnetofunknownprimaryandclinicallysuspectednetevaluationofga68dotatocpetctandin111dtpaoctreotidespectct
_version_ 1717810403770105856

Similar Items